{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:37:23Z","timestamp":1792190243184,"version":"4.4.0"},"reference-count":446,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma guidelines for the diagnosis and management of asthma for adults and children, which is developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up to date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is aligned for age groups: adults, adolescents, children aged 5\u201312 years, and children aged less than 5 years. SINA guidelines have focused more on personalized approaches reflecting better understanding of disease heterogeneity with the integration of recommendations related to biologic agents, evidence-based updates on treatment, and the role of immunotherapy in management. Medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and the current situation at national and regional levels. There is also an emphasis on patient\u2013doctor partnership in the management that also includes a self-management plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/atm.atm_697_20","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T04:45:02Z","timestamp":1610599502000},"page":"4-56","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":61,"title":["The Saudi Initiative for Asthma - 2021 Update"],"prefix":"10.4103","volume":"16","author":[{"given":"Mohamed S.","family":"Al-Moamary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami A.","family":"Alhaider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Alangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majdy M.","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed O.","family":"Zeitouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed O.","family":"Al Ghobain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah F.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel S.","family":"Al-Harbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan S.","family":"Alorainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Al-Hajjaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20240830","doi-asserted-by":"crossref","first-page":"179","DOI":"10.15537\/smj.2018.2.20974","article-title":"Asthma prevalence among adults in Saudi Arabia","volume":"39","author":"Al Ghobain","year":"2018","journal-title":"Saudi Med J"},{"key":"R3-2-20240830","doi-asserted-by":"crossref","first-page":"8102527","DOI":"10.1155\/2018\/8102527","article-title":"Time trends and regional variation in prevalence of asthma and associated factors in Saudi Arabia: A systematic review and meta-analysis","volume":"2018","author":"Mohamed Hussain","year":"2018","journal-title":"Biomed Res Int"},{"key":"R4-2-20240830","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4236\/ojped.2020.102031","article-title":"Barriers of asthma care among asthmatic children in Saudi Arabia: Maternal perspectives","volume":"10","author":"Alatawi","year":"2020","journal-title":"Open J Pediatr"},{"key":"R5-2-20240830","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00431-018-3306-8","article-title":"Quality of life of the family of children with asthma is not related to asthma severity","volume":"178","author":"Taminskiene","year":"2019","journal-title":"Eur J Pediatr"},{"key":"R6-2-20240830","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/1817-1737.56001","article-title":"The Saudi Initiative for Asthma","volume":"4","author":"Al-Moamary","year":"2009","journal-title":"Ann Thorac Med"},{"key":"R7-2-20240830","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/1817-1737.102166","article-title":"The Saudi Initiative for Asthma - 2012 Update: Guidelines for the diagnosis and management of asthma in adults and children","volume":"7","author":"Al-Moamary","year":"2012","journal-title":"Ann Thorac Med"},{"key":"R8-2-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1817-1737.173196","article-title":"The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children","volume":"11","author":"Al-Moamary","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R9-2-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/atm.ATM_327_18","article-title":"The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children","volume":"14","author":"Al-Moamary","year":"2019","journal-title":"Ann Thorac Med"},{"key":"R11-2-20240830","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/bmj.320.7234.537","article-title":"Systematic reviews and meta-analyses on treatment of asthma: Critical evaluation","volume":"320","author":"Jadad","year":"2000","journal-title":"BMJ"},{"key":"R12-2-20240830","first-page":"714","article-title":"Asthma control assessment using asthma control test among patients attending 5 tertiary care hospitals in Saudi Arabia","volume":"29","author":"Al-Jahdali","year":"2008","journal-title":"Saudi Med J"},{"key":"R13-2-20240830","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MOO.0000000000000262","article-title":"Epidemiology of asthma","volume":"24","author":"Loftus","year":"2016","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R14-2-20240830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/1817-1737.173194","article-title":"Awareness regarding childhood asthma in Saudi Arabia","volume":"11","author":"Al-Harbi","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R15-2-20240830","first-page":"6814","article-title":"Asthma in Saudi Arabia: Risk factors and pharmacotherapy","volume":"6","author":"Hammad","year":"2016","journal-title":"Indo Am J Pharm Res"},{"key":"R16-2-20240830","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3109\/02770903.2014.906608","article-title":"Caregiver knowledge and its relationship to asthma control among children in Saudi Arabia","volume":"51","author":"BinSaeed","year":"2014","journal-title":"J Asthma"},{"key":"R17-2-20240830","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/02770903.2013.876649","article-title":"Determinants of asthma control among children in Saudi Arabia","volume":"51","author":"BinSaeed","year":"2014","journal-title":"J Asthma"},{"key":"R18-2-20240830","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/crj.12090","article-title":"Factors associated with poor asthma control among asthmatic patient visiting emergency department","volume":"8","author":"Ahmed","year":"2014","journal-title":"Clin Respir J"},{"key":"R19-2-20240830","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2466-12-80","article-title":"Factors associated with patient visits to the emergency department for asthma therapy","volume":"12","author":"Al-Jahdali","year":"2012","journal-title":"BMC Pulm Med"},{"key":"R20-2-20240830","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1817-1737.152450","article-title":"Factors associated with poor asthma control in the outpatient clinic setting","volume":"10","author":"Al-Zahrani","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R21-2-20240830","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40733-017-0038-x","article-title":"Assessment of knowledge and education relating to asthma during pregnancy among women of childbearing age","volume":"4","author":"Al Ghobain","year":"2018","journal-title":"Asthma Res Pract"},{"key":"R22-2-20240830","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/atm.ATM_67_19","article-title":"Prevalence and factors associated with adult bronchial asthma in Aseer region, Southwestern Saudi Arabia","volume":"14","author":"Al Ghamdi","year":"2019","journal-title":"Ann Thorac Med"},{"key":"R23-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The 'hygiene hypothesis' for autoimmune and allergic diseases: An update","volume":"160","author":"Okada","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"R24-2-20240830","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2458-12-239","article-title":"Asthma prevalence among 16- to 18-year-old adolescents in Saudi Arabia using the ISAAC questionnaire","volume":"12","author":"Al Ghobain","year":"2012","journal-title":"BMC Public Health"},{"key":"R25-2-20240830","doi-asserted-by":"crossref","first-page":"e36848","DOI":"10.1371\/journal.pone.0036848","article-title":"Prevalence of allergic disorders among primary school-aged children in Madinah, Saudi Arabia: Two-stage cross-sectional survey","volume":"7","author":"Nahhas","year":"2012","journal-title":"PLoS One"},{"key":"R26-2-20240830","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-015-0080-5","article-title":"Prevalence of asthma in Saudi adults: Findings from a national household survey, 2013","volume":"15","author":"Moradi-Lakeh","year":"2015","journal-title":"BMC Pulm Med"},{"key":"R27-2-20240830","doi-asserted-by":"crossref","first-page":"300060519899760","DOI":"10.1177\/0300060519899760","article-title":"Atopy and allergic diseases among Saudi young adults: A cross-sectional study","volume":"48","author":"Alqahtani","year":"2020","journal-title":"J Int Med Res"},{"key":"R28-2-20240830","doi-asserted-by":"crossref","first-page":"965","DOI":"10.12816\/0044345","article-title":"The prevalence of asthma and its related risk factors among the children in Riyadh, Saudi Arabia","volume":"70","author":"Horaib","year":"2018","journal-title":"Egypt J Hosp Med"},{"key":"R30-2-20240830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/atm.ATM_348_18","article-title":"Asthma control and predictive factors among adults in Saudi Arabia: Results from the Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population study","volume":"14","author":"Al-Jahdali","year":"2019","journal-title":"Ann Thorac Med"},{"key":"R31-2-20240830","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaci.2020.07.026","article-title":"Asthma among hospitalized patients with COVID-19 and related outcomes","volume":"146","author":"Lovinsky-Desir","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R33-2-20240830","doi-asserted-by":"crossref","first-page":"545","DOI":"10.15585\/mmwr.mm6918e1","article-title":"Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 - Georgia, March 2020","volume":"69","author":"Gold","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R34-2-20240830","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"R35-2-20240830","first-page":"1","article-title":"Effects of pre-existing morbidities on occurrence of death among COVID-19 disease patients: A systematic review and meta-analysis","volume":"20","author":"Khan","year":"2020","journal-title":"Journal of global health"},{"key":"R36-2-20240830","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: Redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"R37-2-20240830","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/all.13072","article-title":"Allergy in severe asthma","volume":"72","author":"Del Giacco","year":"2017","journal-title":"Allergy"},{"key":"R38-2-20240830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ni.3049","article-title":"The immunology of asthma","volume":"16","author":"Lambrecht","year":"2015","journal-title":"Nat Immunol"},{"key":"R39-2-20240830","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nm.3300","article-title":"Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma","volume":"19","author":"Brusselle","year":"2013","journal-title":"Nat Med"},{"key":"R40-2-20240830","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/all.12136","article-title":"Three phenotypes of adult-onset asthma","volume":"68","author":"Amelink","year":"2013","journal-title":"Allergy"},{"key":"R41-2-20240830","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"N Engl J Med"},{"key":"R42-2-20240830","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(17)33311-1","article-title":"Asthma","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"key":"R43-2-20240830","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2012.05.031","article-title":"Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo","volume":"130","author":"Park","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R44-2-20240830","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2222.2011.03917.x","article-title":"Lung damage and airway remodelling in severe asthma","volume":"42","author":"Brightling","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"R45-2-20240830","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1513\/pats.200808-089RM","article-title":"Remodeling in asthma","volume":"6","author":"Bergeron","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"R46-2-20240830","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"N Engl J Med"},{"key":"R47-2-20240830","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/1817-1737.140120","article-title":"Corticosteroids in the treatment of acute asthma","volume":"9","author":"Alangari","year":"2014","journal-title":"Ann Thorac Med"},{"key":"R48-2-20240830","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"START Investigators Group. Severe exacerbations and decline in lung function in asthma","volume":"179","author":"O'Byrne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R49-2-20240830","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaci.2011.11.046","article-title":"Recurrent severe exacerbations in early life and reduced lung function at school age","volume":"129","author":"O'Brian","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R50-2-20240830","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1042\/CS20160253","article-title":"Pathogenesis of asthma: Implications for precision medicine","volume":"131","author":"Russell","year":"2017","journal-title":"Clin Sci (Lond"},{"key":"R51-2-20240830","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaci.2005.01.054","article-title":"Patterns of asthma control: A 3-year analysis of patient claims","volume":"115","author":"Stempel","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"R52-2-20240830","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/rccm.201808-1516OC","article-title":"exacerbation patterns in adults with asthma in England. A population-based study","volume":"199","author":"Bloom","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R53-2-20240830","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4104\/pcrj.2009.00020","article-title":"The prevalence of asthma in patients with obstructive sleep apnoea","volume":"18","author":"Alharbi","year":"2009","journal-title":"Prim Care Respir J"},{"key":"R54-2-20240830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40248-019-0172-9","article-title":"Obstructive sleep apnea and comorbidities: A dangerous liaison","volume":"14","author":"Bonsignore","year":"2019","journal-title":"Multidiscip Respir Med"},{"key":"R55-2-20240830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/1817-1737.62467","article-title":"Asthma and allergic rhinitis: Linked in treatment and outcomes","volume":"5","author":"Price","year":"2010","journal-title":"Ann Thorac Med"},{"key":"R56-2-20240830","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MCP.0000000000000640","article-title":"The impact of comorbidities on severe asthma","volume":"26","author":"Rogliani","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"R57-2-20240830","doi-asserted-by":"crossref","first-page":"100106","DOI":"10.1016\/j.waojou.2020.100106","article-title":"International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies","volume":"13","author":"Naclerio","year":"2020","journal-title":"World Allergy Organ J"},{"key":"R58-2-20240830","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1440-1843.2002.00378.x","article-title":"Chronic cough at a non-teaching hospital: Are extrapulmonary causes overlooked?","volume":"7","author":"Al-Mobeireek","year":"2002","journal-title":"Respirology"},{"key":"R59-2-20240830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/1817-1737.25868","article-title":"Unusual cause of respiratory distress misdiagnosed as refractory asthma","volume":"1","author":"Al-Otair","year":"2006","journal-title":"Ann Thorac Med"},{"key":"R61-2-20240830","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1155\/2007\/816132","article-title":"Asthma symptoms do not predict spirometry","volume":"14","author":"Cowie","year":"2007","journal-title":"Can Respir J"},{"key":"R62-2-20240830","doi-asserted-by":"crossref","first-page":"101903","DOI":"10.1016\/j.pupt.2020.101903","article-title":"Determinants of response to bronchodilator in patients with cough variant asthma- A randomized, single-blinded, placebo-controlled study","volume":"61","author":"Yi","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"key":"R63-2-20240830","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2016.11.037","article-title":"Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough: A systematic review and meta-analysis","volume":"140","author":"Song","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R64-2-20240830","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/oemed-2018-105434","article-title":"Performance of specific immunoglobulin E tests for diagnosing occupational asthma: A systematic review and meta-analysis","volume":"76","author":"Lux","year":"2019","journal-title":"Occup Environ Med"},{"key":"R65-2-20240830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1398-9995.2006.01308.x","article-title":"Asthma control or severity: That is the question","volume":"62","author":"Humbert","year":"2007","journal-title":"Allergy"},{"key":"R66-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.02221-2016","article-title":"Inducible laryngeal obstruction: An official joint European Respiratory Society and European Laryngological Society statement","volume":"50","author":"Halvorsen","year":"2017","journal-title":"Eur Respir J"},{"key":"R67-2-20240830","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000170380","article-title":"International differences in asthma guidelines for children","volume":"148","author":"Cope","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"R68-2-20240830","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.jaip.2019.04.026","article-title":"Patient perceptions of living with severe asthma: Challenges to effective management","volume":"7","author":"Apps","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R69-2-20240830","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02770903.2018.1553050","article-title":"Key factors associated with uncontrolled asthma - The asthma control in Latin America study","volume":"57","author":"Neffen","year":"2020","journal-title":"J Asthma"},{"key":"R71-2-20240830","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1183\/09031936.00173710","article-title":"Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT)","volume":"38","author":"Koolen","year":"2011","journal-title":"Eur Respir J"},{"key":"R72-2-20240830","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.rmed.2013.07.003","article-title":"Asthma control measurement using five different questionnaires: A prospective study","volume":"107","author":"Vermeulen","year":"2013","journal-title":"Respir Med"},{"key":"R73-2-20240830","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","article-title":"Asthma control test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists","volume":"117","author":"Schatz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R74-2-20240830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: A survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R75-2-20240830","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/1817-1737.39635","article-title":"Validation of the Arabic version of the asthma control test","volume":"3","author":"Lababidi","year":"2008","journal-title":"Ann Thorac Med"},{"key":"R76-2-20240830","first-page":"546","article-title":"Levels of acceptance of asthma control test questionnaire among Saudi patients attending 5 tertiary care hospitals in Saudi Arabia","volume":"30","author":"Alanezi","year":"2009","journal-title":"Saudi Med J"},{"key":"R77-2-20240830","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2466-12-14","article-title":"Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: A randomized controlled trial","volume":"12","author":"Al Moamary","year":"2012","journal-title":"BMC Pulm Med"},{"key":"R78-2-20240830","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the asthma control test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R79-2-20240830","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.rmed.2006.07.005","article-title":"TENOR Study Group. Recent asthma exacerbations: A key predictor of future exacerbations","volume":"101","author":"Miller","year":"2007","journal-title":"Respir Med"},{"key":"R80-2-20240830","first-page":"87","article-title":"Characteristics and outcomes of treatment in status asthmaticus patients at emergency department","volume":"37","author":"Amnuaypattanapon","year":"2019","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R81-2-20240830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R82-2-20240830","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1183\/09031936.00155307","article-title":"A new perspective on concepts of asthma severity and control","volume":"32","author":"Taylor","year":"2008","journal-title":"Eur Respir J"},{"key":"R83-2-20240830","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"R84-2-20240830","first-page":"569","article-title":"Perception of the role of inhaled corticosteroids and factors affecting compliance among asthmatic adult patients","volume":"28","author":"Al-Jahdali","year":"2007","journal-title":"Saudi Med J"},{"key":"R85-2-20240830","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1186\/s12889-020-09259-3","article-title":"Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS\/LABA fixed dose combinations: A dual rapid literature review","volume":"20","author":"Noibi","year":"2020","journal-title":"BMC Public Health"},{"key":"R86-2-20240830","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/02770903.2019.1591442","article-title":"Inhalation technique and asthma outcomes with different corticosteroid-containing inhaler devices","volume":"57","author":"Jane\u017ei\u010d","year":"2020","journal-title":"J Asthma"},{"key":"R87-2-20240830","first-page":"23","article-title":"Assessment of educational inhaler technique interventions among community pharmacists: A systematic review","volume":"9","author":"Hussain","year":"2020","journal-title":"Integr Pharm Res Pract"},{"key":"R88-2-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40733-020-00056-8","article-title":"A nationwide study of asthma correlates among adolescents in Saudi Arabia","volume":"6","author":"Musharrafieh","year":"2020","journal-title":"Asthma Res Pract"},{"key":"R89-2-20240830","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.2408006","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study","volume":"170","author":"Barnes","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R90-2-20240830","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/thorax.2003.011858","article-title":"Written action plans for asthma: An evidence-based review of the key components","volume":"59","author":"Gibson","year":"2004","journal-title":"Thorax"},{"key":"R93-2-20240830","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3325\/cmj.2011.52.637","article-title":"Parental perceptions and beliefs about childhood asthma: A cross-sectional study","volume":"52","author":"Zaraket","year":"2011","journal-title":"Croat Med J"},{"key":"R94-2-20240830","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.26719\/2010.16.11.1153","article-title":"Asthma knowledge and behaviours among mothers of asthmatic children in Aseer, South-West Saudi Arabia","volume":"16","author":"Al-Binali","year":"2010","journal-title":"East Mediterr Health J"},{"key":"R95-2-20240830","first-page":"921","article-title":"Recurrent visits and admissions of children with asthma in Central Saudi Arabia","volume":"31","author":"Al-Yami","year":"2010","journal-title":"Saudi Med J"},{"key":"R96-2-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15398285.2014.982050","article-title":"Online health information needs for patients with asthma in Saudi Arabia","volume":"19","author":"Basyouni","year":"2015","journal-title":"J Consum Health Internet"},{"key":"R97-2-20240830","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/1817-1737.25866","article-title":"Impact of an extensive asthma education campaign for physicians on their drug prescription practices","volume":"1","author":"Al-Shimemeri","year":"2006","journal-title":"Ann Thorac Med"},{"key":"R98-2-20240830","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bcpt.13344","article-title":"Pharmaceutical care for adult asthma patients: A controlled intervention one-year follow-up study","volume":"126","author":"Khdour","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R100-2-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1817-1737.146878","article-title":"Status of respiratory care profession in Saudi Arabia: A national survey","volume":"10","author":"Alotaibi","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R101-2-20240830","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2017.04.024","article-title":"NIAID, NIEHS, NHLBI, and MCAN Workshop Report: The indoor environment and childhood asthma-implications for home environmental intervention in asthma prevention and management","volume":"140","author":"Gold","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R102-2-20240830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1817-1737.146857","article-title":"The effect of sand storms on acute asthma in Riyadh, Saudi Arabia","volume":"10","author":"Alangari","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R103-2-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/1817-1737.167065","article-title":"The Saudi Thoracic Society guidelines for influenza vaccinations","volume":"10","author":"Zeitouni","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R104-2-20240830","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000506336","article-title":"Influencing factors for influenza vaccination among south korean adolescents with asthma based on a nationwide cross-sectional study","volume":"181","author":"Kyung","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"R105-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"R106-2-20240830","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/1817-1737.180030","article-title":"The Saudi Thoracic Society Pneumococcal Vaccination Guidelines-2016","volume":"11","author":"Alharbi","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R107-2-20240830","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(03)12891-7","article-title":"Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial","volume":"361","author":"Pauwels","year":"2003","journal-title":"Lancet"},{"key":"R108-2-20240830","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm\/148.4_Pt_2.S1","article-title":"Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992","volume":"148","author":"Barnes","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R109-2-20240830","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1081-1206(10)61859-5","article-title":"Levalbuterol: Pharmacologic properties and use in the treatment of pediatric and adult asthma","volume":"90","author":"Berger","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R110-2-20240830","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): A randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"R111-2-20240830","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R112-2-20240830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma","volume":"171","author":"O'Byrne","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R113-2-20240830","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N Engl J Med"},{"key":"R114-2-20240830","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O'Byrne","year":"2018","journal-title":"N Engl J Med"},{"key":"R115-2-20240830","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N Engl J Med"},{"key":"R116-2-20240830","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1164\/ajrccm.157.6.9708092","article-title":"Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma","volume":"157","author":"Turner","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R117-2-20240830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.rmed.2019.04.020","article-title":"Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma","volume":"152","author":"Graff","year":"2019","journal-title":"Respir Med"},{"key":"R118-2-20240830","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2222.2001.01088.x","article-title":"A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma","volume":"31","author":"Wilson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"R119-2-20240830","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/02813432.2016.1160629","article-title":"Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: A systematic review","volume":"34","author":"Pols","year":"2016","journal-title":"Scand J Prim Health Care"},{"key":"R121-2-20240830","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): A 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"R122-2-20240830","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"key":"R123-2-20240830","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.rmed.2007.12.029","article-title":"Effect of disease duration on dose-response of inhaled budesonide in asthma","volume":"102","author":"Selroos","year":"2008","journal-title":"Respir Med"},{"key":"R124-2-20240830","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.18203\/2349-3291.ijcp20172542","article-title":"To evaluate the efficacy of nebulized budesonide compared to oral prednisolone in the management of moderate exacerbation of acute asthma","volume":"4","author":"Sharma","year":"2017","journal-title":"Int J Contemp Pediatr"},{"key":"R125-2-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1398-9995.1999.tb04391.x","article-title":"How do we monitor asthma control?","volume":"54","author":"Sont","year":"1999","journal-title":"Allergy"},{"key":"R126-2-20240830","doi-asserted-by":"crossref","first-page":"1701103","DOI":"10.1183\/13993003.01103-2017","article-title":"The paradoxes of asthma management: Time for a new approach?","volume":"50","author":"O'Byrne","year":"2017","journal-title":"Eur Respir J"},{"key":"R127-2-20240830","doi-asserted-by":"crossref","first-page":"e000217","DOI":"10.1136\/bmjresp-2017-000217","article-title":"Description of the protocol for the PRACTICAL study: A randomised controlled trial of the efficacy and safety of ICS\/LABA reliever therapy in asthma","volume":"4","author":"Fingleton","year":"2017","journal-title":"BMJ Open Respir Res"},{"key":"R128-2-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(16)31399-X","article-title":"Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: A post-hoc efficacy analysis of the START study","volume":"389","author":"Reddel","year":"2017","journal-title":"Lancet"},{"key":"R129-2-20240830","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1398-9995.2007.01394.x","article-title":"Mild asthma: An expert review on epidemiology, clinical characteristics and treatment recommendations","volume":"62","author":"Dusser","year":"2007","journal-title":"Allergy"},{"key":"R130-2-20240830","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/thx.2004.023754","article-title":"Initial starting dose of inhaled corticosteroids in adults with asthma: A systematic review","volume":"59","author":"Powell","year":"2004","journal-title":"Thorax"},{"key":"R131-2-20240830","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","article-title":"Treatment of asthma with drugs modifying the leukotriene pathway","volume":"340","author":"Drazen","year":"1999","journal-title":"N Engl J Med"},{"key":"R132-2-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(16)31399-X","article-title":"Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: A post-hoc efficacy analysis of the START study","volume":"389","author":"Reddel","year":"2017","journal-title":"Lancet"},{"key":"R133-2-20240830","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1164\/ajrccm.164.8.2104102","article-title":"Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial","volume":"164","author":"O'Byrne","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R134-2-20240830","first-page":"CD006922","article-title":"Inhaled steroids with and without regular salmeterol for asthma: Serious adverse events","volume":"12","author":"Cates","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R135-2-20240830","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1716868","article-title":"Combined analysis of asthma safety trials of long-acting \u03b22-agonists","volume":"378","author":"Busse","year":"2018","journal-title":"N Engl J Med"},{"key":"R136-2-20240830","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJMp1002074","article-title":"The FDA and safe use of long-acting beta-agonists in the treatment of asthma","volume":"362","author":"Chowdhury","year":"2010","journal-title":"N Engl J Med"},{"key":"R137-2-20240830","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/1817-1737.62468","article-title":"New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist","volume":"5","author":"Koshak","year":"2010","journal-title":"Ann Thorac Med"},{"key":"R138-2-20240830","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1183\/09031936.00128505","article-title":"The correlation between asthma control and health status: The GOAL study","volume":"29","author":"Bateman","year":"2007","journal-title":"Eur Respir J"},{"key":"R139-2-20240830","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1183\/09031936.00064513","article-title":"Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma","volume":"43","author":"O'Byrne","year":"2014","journal-title":"Eur Respir J"},{"key":"R140-2-20240830","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1378\/chest.13-0178","article-title":"Efficacy and safety of fluticasone furoate\/vilanterol compared with fluticasone propionate\/salmeterol combination in adult and adolescent patients with persistent asthma: A randomized trial","volume":"144","author":"Woodcock","year":"2013","journal-title":"Chest"},{"key":"R141-2-20240830","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"R142-2-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5694\/j.1326-5377.2003.tb05167.x","article-title":"Inhaled corticosteroid doses in asthma: An evidence-based approach","volume":"178","author":"Powell","year":"2003","journal-title":"Med J Aust"},{"key":"R143-2-20240830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2005.10.012","article-title":"Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma","volume":"117","author":"Zeiger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R144-2-20240830","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/thorax.58.3.204","article-title":"Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma","volume":"58","author":"Vaquerizo","year":"2003","journal-title":"Thorax"},{"key":"R145-2-20240830","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/thx.2007.081596","article-title":"Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review","volume":"63","author":"Joos","year":"2008","journal-title":"Thorax"},{"key":"R146-2-20240830","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2213-2600(14)70297-8","article-title":"Regular treatment for moderate asthma: Guidelines hold true","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"key":"R147-2-20240830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-15-61","article-title":"Tiotropium Respimat\u00ae in asthma: A double-blind, randomised, dose-ranging study in adult patients with moderate asthma","volume":"15","author":"Beeh","year":"2014","journal-title":"Respir Res"},{"key":"R148-2-20240830","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4187\/respcare.02703","article-title":"Tiotropium versus placebo for inadequately controlled asthma: A meta-analysis","volume":"59","author":"Tian","year":"2014","journal-title":"Respir Care"},{"key":"R149-2-20240830","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"key":"R150-2-20240830","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R151-2-20240830","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMe1009429","article-title":"Anticholinergics for patients with asthma?","volume":"363","author":"Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"R152-2-20240830","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2018.2757","article-title":"Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: A systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"R153-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1817-1737.74268","article-title":"Difficult-to-treat asthma, is it really difficult?","volume":"6","author":"Al-Hajjaj","year":"2011","journal-title":"Ann Thorac Med"},{"key":"R154-2-20240830","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group","volume":"337","author":"Pauwels","year":"1997","journal-title":"N Engl J Med"},{"key":"R156-2-20240830","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R157-2-20240830","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"key":"R158-2-20240830","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/pai.12759","article-title":"Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: A systematic review","volume":"28","author":"Rodrigo","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"R160-2-20240830","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thorax.58.3.211","article-title":"Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma","volume":"58","author":"Price","year":"2003","journal-title":"Thorax"},{"key":"R162-2-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/ajrccm.151.2.7842186","article-title":"Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids","volume":"151","author":"Rivington","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R163-2-20240830","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jaip.2019.08.051","article-title":"Inhaled corticosteroids in acute asthma: A systemic review and meta-analysis","volume":"8","author":"Kearns","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R164-2-20240830","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R165-2-20240830","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5114\/pdia.2014.40973","article-title":"Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation","volume":"31","author":"Skiepko","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"R166-2-20240830","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.rmed.2009.09.011","article-title":"Effect of omalizumab on peripheral blood eosinophilia in allergic asthma","volume":"104","author":"Massanari","year":"2010","journal-title":"Respir Med"},{"key":"R167-2-20240830","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.rmed.2007.01.011","article-title":"Predicting and evaluating response to omalizumab in patients with severe allergic asthma","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir Med"},{"key":"R168-2-20240830","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1398-9995.2010.02522.x","article-title":"Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma","volume":"66","author":"Bousquet","year":"2011","journal-title":"Allergy"},{"key":"R169-2-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1817-1737.94519","article-title":"Personalized medicine for asthma: Are we there yet?","volume":"7","author":"Poon","year":"2012","journal-title":"Ann Thorac Med"},{"key":"R170-2-20240830","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"R171-2-20240830","doi-asserted-by":"crossref","first-page":"1701782","DOI":"10.1183\/13993003.01782-2017","article-title":"Care pathways for the selection of a biologic in severe asthma","volume":"50","author":"Bousquet","year":"2020","journal-title":"Eur Respir J"},{"key":"R172-2-20240830","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid-sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"R173-2-20240830","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/1389450119666180212120012","article-title":"blood eosinophils as biomarkers to drive treatment choices in asthma and COPD","volume":"19","author":"Kostikas","year":"2018","journal-title":"Curr Drug Targets"},{"key":"R174-2-20240830","first-page":"S18","article-title":"Asthma","volume":"4","author":"Cockcroft","year":"2020","journal-title":"Can J Respir Crit Care Sleep Med"},{"key":"R176-2-20240830","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1164\/ajrccm.151.2.7842191","article-title":"Asthma self-management education program by home monitoring of peak expiratory flow","volume":"151","author":"Ignacio-Garcia","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R177-2-20240830","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.326.7399.1115","article-title":"Stepping down inhaled corticosteroids in asthma: Randomised controlled trial","volume":"326","author":"Hawkins","year":"2003","journal-title":"BMJ"},{"key":"R179-2-20240830","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.rmed.2005.11.030","article-title":"Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma","volume":"100","author":"Boulet","year":"2006","journal-title":"Respir Med"},{"key":"R180-2-20240830","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2012.11.038","article-title":"The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trials","volume":"131","author":"Rank","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R181-2-20240830","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinternmed.2012.3250","article-title":"Long-acting \u03b22-agonist step-off in patients with controlled asthma","volume":"172","author":"Brozek","year":"2012","journal-title":"Arch Intern Med"},{"key":"R182-2-20240830","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1440-1843.2004.00635.x","article-title":"Budesonide once versus twice-daily administration: Meta-analysis","volume":"9","author":"Masoli","year":"2004","journal-title":"Respirology"},{"key":"R183-2-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1465-9921-7-13","article-title":"Budesonide\/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol","volume":"7","author":"Bateman","year":"2006","journal-title":"Respir Res"},{"key":"R184-2-20240830","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00128072-200305070-00005","article-title":"Safety of the newer inhaled corticosteroids in childhood asthma","volume":"5","author":"Randell","year":"2003","journal-title":"Paediatr Drugs"},{"key":"R185-2-20240830","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: A practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R186-2-20240830","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"R187-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18176\/jiaci.0149","article-title":"Specific allergen immunotherapy for the treatment of allergic asthma: A review of current evidence","volume":"27","author":"Dominguez-Ortega","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R188-2-20240830","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaip.2016.11.024","article-title":"The potential role of allergen immunotherapy in stepping down asthma treatment","volume":"5","author":"Demoly","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R189-2-20240830","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"R190-2-20240830","doi-asserted-by":"crossref","first-page":"e20173833","DOI":"10.1542\/peds.2017-3833","article-title":"Allergen-specific immunotherapy in the treatment of pediatric asthma: A systematic review","volume":"141","author":"Rice","year":"2018","journal-title":"Pediatrics"},{"key":"R191-2-20240830","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.9778\/cmajo.20160066","article-title":"Allergen immunotherapy for the treatment of allergic rhinitis and\/or asthma: An umbrella review","volume":"5","author":"Elliott","year":"2017","journal-title":"CMAJ Open"},{"key":"R192-2-20240830","doi-asserted-by":"crossref","first-page":"b494","DOI":"10.1136\/bmj.b494","article-title":"Difficult to treat asthma in adults","volume":"338","author":"Currie","year":"2009","journal-title":"BMJ"},{"key":"R193-2-20240830","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines-2016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R194-2-20240830","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1398-9995.2006.01254.x","article-title":"TENOR Study Group. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma","volume":"62","author":"Sullivan","year":"2007","journal-title":"Allergy"},{"key":"R195-2-20240830","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.98.12061322","article-title":"Costs of asthma according to the degree of severity","volume":"12","author":"Serra-Batlles","year":"1998","journal-title":"Eur Respir J"},{"key":"R196-2-20240830","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1524-4733.2007.00229.x","article-title":"Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma","volume":"11","author":"Chen","year":"2008","journal-title":"Value Health"},{"key":"R197-2-20240830","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/1817-1737.191874","article-title":"Ketamine versus aminophylline for acute asthma in children: A randomized, controlled trial","volume":"11","author":"Tiwari","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R198-2-20240830","doi-asserted-by":"crossref","first-page":"1440868","DOI":"10.1080\/20018525.2018.1440868","article-title":"Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults","volume":"5","author":"Porsbjerg","year":"2018","journal-title":"Eur Clin Respir J"},{"key":"R199-2-20240830","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1378\/chest.07-0713","article-title":"Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: Insights from the TENOR study","volume":"132","author":"Lee","year":"2007","journal-title":"Chest"},{"key":"R200-2-20240830","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/thorax.57.12.1034","article-title":"Psychological, social and health behaviour risk factors for deaths certified as asthma: A national case-control study","volume":"57","author":"Sturdy","year":"2002","journal-title":"Thorax"},{"key":"R201-2-20240830","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.06.00022606","article-title":"Risk factors of frequent exacerbations in difficult-to-treat asthma","volume":"27","author":"Butler","year":"2006","journal-title":"Eur Respir J"},{"key":"R202-2-20240830","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1365-2222.2005.02281.x","article-title":"Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: An analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire","volume":"35","author":"Gaga","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"R203-2-20240830","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1398-9995.2007.01383.x","article-title":"Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients","volume":"62","author":"Sullivan","year":"2007","journal-title":"Allergy"},{"key":"R204-2-20240830","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1183\/09031936.03.00017003","article-title":"Systematic assessment of difficult-to-treat asthma","volume":"22","author":"Robinson","year":"2003","journal-title":"Eur Respir J"},{"key":"R205-2-20240830","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/1817-1737.140130","article-title":"Allergic bronchopulmonary aspergillosis: A clinical review of 24 patients: Are we right in frequent serologic monitoring?","volume":"9","author":"Natarajan","year":"2014","journal-title":"Ann Thorac Med"},{"key":"R206-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/JAS-200044744","article-title":"Current thinking on the relationship between rhinosinusitis and asthma","volume":"42","author":"Jani","year":"2005","journal-title":"J Asthma"},{"key":"R207-2-20240830","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.drudis.2016.11.008","article-title":"New concepts in asthma: Clinical phenotypes and pathophysiological mechanisms","volume":"22","author":"Koczulla","year":"2017","journal-title":"Drug Discov Today"},{"key":"R208-2-20240830","first-page":"1338","article-title":"Efficacy of omalizumab in patients with severe asthma using the asthma health questionnaire and asthma control test","volume":"63","author":"Saji","year":"2014","journal-title":"Arerugi"},{"key":"R209-2-20240830","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2500\/aap.2012.33.3527","article-title":"Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: A 6-year pragmatic data review","volume":"33","author":"Storms","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"R210-2-20240830","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/thx.2010.137414","article-title":"British Thoracic Society Difficult Asthma Network. Refractory asthma in the UK: Cross-sectional findings from a UK multicentre registry","volume":"65","author":"Heaney","year":"2010","journal-title":"Thorax"},{"key":"R211-2-20240830","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.154.7.3500","article-title":"Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma","volume":"154","author":"Adcock","year":"1995","journal-title":"J Immunol"},{"key":"R212-2-20240830","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1513\/pats.200402-014MS","article-title":"Corticosteroid resistance in airway disease","volume":"1","author":"Barnes","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"R213-2-20240830","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.54.10.956","article-title":"Pseudo-steroid resistant asthma","volume":"54","author":"Ayres","year":"1999","journal-title":"Thorax"},{"key":"R214-2-20240830","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)60285-2","article-title":"Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma","volume":"101","author":"Campbell","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R215-2-20240830","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): A randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"R216-2-20240830","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pharmthera.2017.07.015","article-title":"Emerging understanding of the mechanism of action of bronchial thermoplasty in asthma","volume":"181","author":"d'Hooghe","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R217-2-20240830","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2500\/aap.2015.36.3857","article-title":"Bronchial thermoplasty: Where there is smoke, there is fire","volume":"36","author":"Iyer","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"R218-2-20240830","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1378\/chest.11-1390","article-title":"Counterpoint: Efficacy of bronchial thermoplasty for patients with severe asthma. Is there sufficient evidence? Not yet","volume":"140","author":"Michaud","year":"2011","journal-title":"Chest"},{"key":"R219-2-20240830","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/147323001103900102","article-title":"Meta-analysis of the efficacy and safety of bronchial thermoplasty in patients with moderate-to-severe persistent asthma","volume":"39","author":"Wu","year":"2011","journal-title":"J Int Med Res"},{"key":"R220-2-20240830","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","article-title":"Epidemiology of asthma in children and adults","volume":"7","author":"Dharmage","year":"2019","journal-title":"Front Pediatr"},{"key":"R221-2-20240830","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"R222-2-20240830","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijpam.2019.02.004","article-title":"The prevalence of childhood asthma in Saudi Arabia","volume":"6","author":"Alahmadi","year":"2019","journal-title":"Int J Pediatr Adolesc Med"},{"key":"R223-2-20240830","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/atm.ATM_258_18","article-title":"Fatal and near-fatal thunderstorm asthma epidemic in a desert country","volume":"14","author":"Ali","year":"2019","journal-title":"Ann Thorac Med"},{"key":"R224-2-20240830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/ACI.0000000000000333","article-title":"Near-fatal asthma: A heterogeneous clinical entity","volume":"17","author":"Serrano-Pariente","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R225-2-20240830","first-page":"116","article-title":"Near fatal asthma: Treatment and prevention","volume":"48","author":"D'Amato","year":"2016","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"R226-2-20240830","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/1817-1737.124441","article-title":"Risk factors, management and outcomes of patients admitted with near fatal asthma to a tertiary care hospital in Riyadh","volume":"9","author":"Al-Dorzi","year":"2014","journal-title":"Ann Thorac Med"},{"key":"R227-2-20240830","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaci.2016.06.054","article-title":"Acute asthma, prognosis, and treatment","volume":"139","author":"Fergeson","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R228-2-20240830","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5144\/0256-4947.2002.29","article-title":"Pattern and risk factors associated with hospital emergency visits among schoolboys with bronchial asthma in Al-Khobar","volume":"22","author":"Al-Dawood","year":"2002","journal-title":"Ann Saudi Med"},{"key":"R229-2-20240830","first-page":"1959","article-title":"Childhood asthma: Treatment update","volume":"71","author":"Courtney","year":"2005","journal-title":"Am Fam Physician"},{"key":"R230-2-20240830","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.162.2.9907151","article-title":"The effect of age and duration of disease on airway structure in fatal asthma","volume":"162","author":"Bai","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R231-2-20240830","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/thx.2010.155259","article-title":"Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma","volume":"66","author":"Perrin","year":"2011","journal-title":"Thorax"},{"key":"R232-2-20240830","doi-asserted-by":"crossref","first-page":"2301712","DOI":"10.1155\/2020\/2301712","article-title":"High-flow nasal cannula: A promising oxygen therapy for patients with severe bronchial asthma complicated with respiratory failure","volume":"2020","author":"Geng","year":"2020","journal-title":"Can Respir J"},{"key":"R233-2-20240830","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12890-016-0223-3","article-title":"Efficacy and safety of ipratropium bromide\/albuterol compared with albuterol in patients with moderate-to-severe asthma: A randomized controlled trial","volume":"16","author":"Donohue","year":"2016","journal-title":"BMC Pulm Med"},{"key":"R234-2-20240830","first-page":"243","article-title":"Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma","volume":"66","author":"Memon","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"R236-2-20240830","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/thorax.55.12.1007","article-title":"Case-control study of severe life threatening asthma (SLTA) in adults: Demographics, health care, and management of the acute attack","volume":"55","author":"Kolbe","year":"2000","journal-title":"Thorax"},{"key":"R237-2-20240830","first-page":"531","article-title":"Management of an acute asthma attack","volume":"34","author":"Barnard","year":"2005","journal-title":"Aust Fam Physician"},{"key":"R238-2-20240830","first-page":"CD011050","article-title":"Intravenous magnesium sulfate for treating children with acute asthma in the emergency department","volume":"4","author":"Griffiths","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R239-2-20240830","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.121.5.1407","article-title":"Near-fatal asthma: A population-based study of risk factors","volume":"121","author":"Mitchell","year":"2002","journal-title":"Chest"},{"key":"R240-2-20240830","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1183\/09031936.02.00241502","article-title":"High Risk Asthma Research Group. Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma","volume":"19","author":"Plaza","year":"2002","journal-title":"Eur Respir J"},{"key":"R242-2-20240830","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bja.2020.05.065","article-title":"Outcomes of the NHS England National Extracorporeal Membrane Oxygenation Service for adults with respiratory failure: A multicentre observational cohort study","volume":"125","author":"Warren","year":"2020","journal-title":"Br J Anaesth"},{"key":"R243-2-20240830","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/1817-1737.53347","article-title":"Pulmonary manifestations of gastroesophageal reflux disease","volume":"4","author":"Gaude","year":"2009","journal-title":"Ann Thorac Med"},{"key":"R244-2-20240830","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/gut.2007.122465","article-title":"The association between gastro-oesophageal reflux disease and asthma: A systematic review","volume":"56","author":"Havemann","year":"2007","journal-title":"Gut"},{"key":"R245-2-20240830","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrgastro.2016.91","article-title":"Respiratory disease and the oesophagus: Reflux, reflexes and microaspiration","volume":"13","author":"Houghton","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R246-2-20240830","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMe0900117","article-title":"Silent acid reflux and asthma control","volume":"360","author":"Asano","year":"2009","journal-title":"N Engl J Med"},{"key":"R247-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2007.01551.x","article-title":"Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN","volume":"62","author":"Cruz","year":"2007","journal-title":"Allergy"},{"key":"R249-2-20240830","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12543","article-title":"Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma","volume":"278","author":"Hansbro","year":"2017","journal-title":"Immunol Rev"},{"key":"R250-2-20240830","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","article-title":"Obesity and asthma","volume":"141","author":"Peters","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R251-2-20240830","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jaci.2014.09.016","article-title":"Peripheral airways dysfunction in obesity reflects increased bronchomotor tone","volume":"135","author":"Desai","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R252-2-20240830","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cea.12004","article-title":"Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: A randomized trial","volume":"43","author":"Scott","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"R253-2-20240830","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/all.12106","article-title":"Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (Part I)","volume":"68","author":"Moreira","year":"2013","journal-title":"Allergy"},{"key":"R254-2-20240830","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.rmed.2011.12.012","article-title":"Effect of bariatric surgery on airway response and lung function in obese subjects with asthma","volume":"106","author":"Boulet","year":"2012","journal-title":"Respir Med"},{"key":"R255-2-20240830","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.12659\/MSM.907284","article-title":"WeChat public account use improves clinical control of cough-variant asthma: A randomized controlled trial","volume":"24","author":"Cao","year":"2018","journal-title":"Med Sci Monit"},{"key":"R256-2-20240830","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.mcna.2016.04.008","article-title":"Evidence-based evaluation and management of chronic cough","volume":"100","author":"Achilleos","year":"2016","journal-title":"Med Clin North Am"},{"key":"R257-2-20240830","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2006.065144","article-title":"British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults","volume":"61","author":"Morice","year":"2006","journal-title":"Thorax"},{"key":"R258-2-20240830","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1081-1206(10)61493-7","article-title":"Effectiveness of montelukast in the treatment of cough variant asthma","volume":"93","author":"Spector","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R259-2-20240830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.otc.2009.11.006","article-title":"Cough due to asthma, cough-variant asthma and non-asthmatic eosinophilic bronchitis","volume":"43","author":"Desai","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"R260-2-20240830","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.jaip.2019.04.048","article-title":"Cough and Eosinophilia","volume":"7","author":"Diver","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R261-2-20240830","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2016.05.029","article-title":"Exercise-induced bronchoconstriction update-2016","volume":"138","author":"Weiler","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R262-2-20240830","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12890-019-0845-3","article-title":"Predictors and reproducibility of exercise-induced bronchoconstriction in cold air","volume":"19","author":"Dre\u00dfler","year":"2019","journal-title":"BMC Pulm Med"},{"key":"R263-2-20240830","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1164\/rccm.201303-0437ST","article-title":"An official American Thoracic Society clinical practice guideline: Exercise-induced bronchoconstriction","volume":"187","author":"Parsons","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R264-2-20240830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thoraxjnl-2013-203557","article-title":"Combination of budesonide\/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction","volume":"69","author":"Lazarinis","year":"2014","journal-title":"Thorax"},{"key":"R265-2-20240830","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease--New prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N Engl J Med"},{"key":"R266-2-20240830","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R267-2-20240830","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R268-2-20240830","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"R269-2-20240830","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","article-title":"The safety of celecoxib in patients with aspirin-sensitive asthma","volume":"46","author":"Woessner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R270-2-20240830","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jaci.2016.09.025","article-title":"Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease","volume":"139","author":"Cahill","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R271-2-20240830","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4168\/aair.2010.2.1.48","article-title":"Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics","volume":"2","author":"Park","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"R272-2-20240830","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jaip.2019.05.043","article-title":"Poorly controlled asthma during pregnancy remains common in the United States","volume":"7","author":"Cohen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R273-2-20240830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chest.2017.08.029","article-title":"Asthma outcomes and management during pregnancy","volume":"153","author":"Bonham","year":"2018","journal-title":"Chest"},{"key":"R274-2-20240830","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/thoraxjnl-2014-206634","article-title":"Asthma exacerbations during the first trimester of pregnancy and congenital malformations: Revisiting the association in a large representative cohort","volume":"70","author":"Blais","year":"2015","journal-title":"Thorax"},{"key":"R275-2-20240830","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1183\/09031936.05.00085704","article-title":"Asthma during pregnancy: Mechanisms and treatment implications","volume":"25","author":"Murphy","year":"2005","journal-title":"Eur Respir J"},{"key":"R276-2-20240830","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijoa.2005.05.005","article-title":"Acute severe asthma presenting in late pregnancy","volume":"15","author":"Holland","year":"2006","journal-title":"Int J Obstet Anesth"},{"key":"R277-2-20240830","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1097\/01.CCM.0000182789.14710.A1","article-title":"Acute asthma in pregnancy","volume":"33","author":"Hanania","year":"2005","journal-title":"Crit Care Med"},{"key":"R278-2-20240830","first-page":"809","article-title":"Is it safe to use inhaled corticosteroids in pregnancy?","volume":"60","author":"Smy","year":"2014","journal-title":"Can Fam Physician"},{"key":"R279-2-20240830","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1191\/0960327106het647oa","article-title":"Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: A systematic meta-analysis review","volume":"25","author":"Rahimi","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"R280-2-20240830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.iac.2005.10.008","article-title":"The effect of pregnancy on the course of asthma","volume":"26","author":"Gluck","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"R281-2-20240830","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpeds.2015.12.066","article-title":"Risk of asthma from cesarean delivery depends on membrane rupture","volume":"171","author":"Sevelsted","year":"2016","journal-title":"J Pediatr"},{"key":"R282-2-20240830","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.anclin.2017.01.007","article-title":"Uterotonic medications: Oxytocin, methylergonovine, carboprost, misoprostol","volume":"35","author":"Vallera","year":"2017","journal-title":"Anesthesiol Clin"},{"key":"R283-2-20240830","first-page":"237","article-title":"Successful pregnancy outcome among women with end-stage renal disease requiring haemodialysis","volume":"107","author":"Arora","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"R284-2-20240830","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9378(12)80020-2","article-title":"Severity of asthma and perinatal outcome","volume":"167","author":"Perlow","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R285-2-20240830","first-page":"731","article-title":"Occupational asthma case finding: A role for primary care","volume":"54","author":"Levy","year":"2004","journal-title":"Br J Gen Pract"},{"key":"R286-2-20240830","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09059180.00004711","article-title":"The management of work-related asthma guidelines: A broader perspective","volume":"21","author":"Baur","year":"2012","journal-title":"Eur Respir Rev"},{"key":"R287-2-20240830","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1183\/09059180.00002912","article-title":"Management of work-related asthma: Guidelines and challenges","volume":"21","author":"Legiest","year":"2012","journal-title":"Eur Respir Rev"},{"key":"R288-2-20240830","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0256-4947.77485","article-title":"Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia","volume":"31","author":"Al Ghobain","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R289-2-20240830","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/thx.2008.108027","article-title":"The overlap syndrome of asthma and COPD: What are its features and how important is it?","volume":"64","author":"Gibson","year":"2009","journal-title":"Thorax"},{"key":"R290-2-20240830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/02770903.2011.555576","article-title":"Overlap syndrome of asthma and COPD predicts low quality of life","volume":"48","author":"Kauppi","year":"2011","journal-title":"J Asthma"},{"key":"R291-2-20240830","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1465-9921-12-127","article-title":"The clinical features of the overlap between COPD and asthma","volume":"12","author":"Hardin","year":"2011","journal-title":"Respir Res"},{"key":"R292-2-20240830","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 Update. An official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R293-2-20240830","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaip.2018.01.023","article-title":"Taming asthma in school-aged children: A comprehensive review","volume":"6","author":"Naja","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R294-2-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2006.10.015","article-title":"Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network","volume":"119","author":"Denlinger","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R295-2-20240830","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fped.2018.00186","article-title":"The burden of pediatric asthma","volume":"6","author":"Ferrante","year":"2018","journal-title":"Front Pediatr"},{"key":"R297-2-20240830","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ppul.23541","article-title":"Misdiagnosis of asthma in schoolchildren","volume":"52","author":"Yang","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"R298-2-20240830","first-page":"52","article-title":"The role of objective tests to support a diagnosis of asthma in children","volume":"33","author":"Danvers","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"R299-2-20240830","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jemermed.2017.01.005","article-title":"Clinical mimics: An emergency medicine-focused review of asthma mimics","volume":"53","author":"Kann","year":"2017","journal-title":"J Emerg Med"},{"key":"R300-2-20240830","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1399-3038.2003.00098.x","article-title":"Chest X-ray investigation in newly discovered asthma","volume":"15","author":"Hederos","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"R302-2-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.aller.2019.06.003","article-title":"Asthma prevalence and risk factors in school children: The RESPIR longitudinal study","volume":"48","author":"Alfonso","year":"2020","journal-title":"Allergol Immunopathol (Madr"},{"key":"R303-2-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpam.2019.02.003","article-title":"Wheezing in children: Approaches to diagnosis and management","volume":"6","author":"Al-Shamrani","year":"2019","journal-title":"Int J Pediatr Adolesc Med"},{"key":"R304-2-20240830","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jpeds.2011.01.057","article-title":"Phenotypic expressions of childhood wheezing and asthma: Implications for therapy","volume":"158","author":"Chipps","year":"2011","journal-title":"J Pediatr"},{"key":"R305-2-20240830","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/ajrccm.163.4.2005049","article-title":"\u201cReactive airways disease\u201d.A lazy term of uncertain meaning that should be abandoned","volume":"163","author":"Fahy","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R306-2-20240830","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1176\/ps.2008.59.10.1211","article-title":"Predictors of major depression six months after admission for outpatient treatment","volume":"59","author":"Weinberger","year":"2008","journal-title":"Psychiatr Serv"},{"key":"R307-2-20240830","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/17455111.2.5.631","article-title":"Pediatric asthma and related allergic and nonallergic diseases: Patient-oriented evidence-based essentials that matter","volume":"2","author":"Weinberger","year":"2008","journal-title":"Pediatric Health"},{"key":"R308-2-20240830","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1817-1737.151437","article-title":"Clinical description of human bocavirus viremia in children with LRTI, Eastern Province, Saudi Arabia","volume":"10","author":"Bubshait","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R309-2-20240830","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2012.02.041","article-title":"Novel severe wheezy young children phenotypes: Boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze","volume":"130","author":"Just","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R310-2-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaci.2012.05.007","article-title":"Predicting who will have asthma at school age among preschool children","volume":"130","author":"Savenije","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R311-2-20240830","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2004.09.020","article-title":"Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma","volume":"114","author":"Guilbert","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R312-2-20240830","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jaci.2010.06.032","article-title":"The Asthma Predictive Index: A very useful tool for predicting asthma in young children","volume":"126","author":"Castro-Rodriguez","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R313-2-20240830","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaip.2012.10.008","article-title":"Evaluation of the modified asthma predictive index in high-risk preschool children","volume":"1","author":"Chang","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R314-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.21321","article-title":"Global strategy for the diagnosis and management of asthma in children 5 years and younger","volume":"46","author":"Pedersen","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"R315-2-20240830","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/1817-1737.118502","article-title":"Pediatric pulmonary services in Saudi Arabia","volume":"8","author":"Yousef","year":"2013","journal-title":"Ann Thorac Med"},{"key":"R316-2-20240830","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1542\/peds.2005-2576","article-title":"Assessment of asthma severity and asthma control in children","volume":"118","author":"Yawn","year":"2006","journal-title":"Pediatrics"},{"key":"R317-2-20240830","doi-asserted-by":"crossref","first-page":"e20170092","DOI":"10.1542\/peds.2017-0092","article-title":"International Variation in Asthma and Bronchiolitis Guidelines","volume":"140","author":"Bakel","year":"2017","journal-title":"Pediatrics"},{"key":"R318-2-20240830","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaci.2006.12.662","article-title":"Development and cross-sectional validation of the childhood asthma control test","volume":"119","author":"Liu","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R320-2-20240830","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2011.08.010","article-title":"Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score","volume":"128","author":"Zeiger","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R321-2-20240830","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1542\/peds.113.2.e87","article-title":"Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing","volume":"113","author":"Bisgaard","year":"2004","journal-title":"Pediatrics"},{"key":"R322-2-20240830","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.109.5.866","article-title":"Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: Results of a randomized outcomes trial","volume":"109","author":"Leflein","year":"2002","journal-title":"Pediatrics"},{"key":"R323-2-20240830","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1542\/peds.2011-2107NNN","article-title":"Use of beclomethasone dipropionate as rescue Treatment for Children With Mild Persistent Asthma (TREXA): A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Simons","year":"2011","journal-title":"Pediatrics"},{"key":"R324-2-20240830","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.intimp.2005.01.007","article-title":"Effects of a short-course of amoxicillin\/clavulanic acid on systemic and mucosal immunity in healthy adult humans","volume":"5","author":"Dufour","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"R326-2-20240830","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa1710988","article-title":"Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations","volume":"378","author":"Jackson","year":"2018","journal-title":"N Engl J Med"},{"key":"R327-2-20240830","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jaci.2008.09.029","article-title":"Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing","volume":"122","author":"Bacharier","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R328-2-20240830","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/eb-2013-101249","article-title":"Inconclusive evidence about the efficacy of diverse strategies for intermittent versus daily inhaled corticosteroids for persistent asthma in adults and children","volume":"19","author":"Reddel","year":"2014","journal-title":"Evid Based Med"},{"key":"R329-2-20240830","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ebch.1984","article-title":"Cochrane in context: Inhaled corticosteroids in children with persistent asthma: Effects on growth and dose-response effects on growth","volume":"9","author":"Zhang","year":"2014","journal-title":"Evid Based Child Health"},{"key":"R330-2-20240830","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/ebch.1989","article-title":"Inhaled corticosteroids in children with persistent asthma: Dose-response effects on growth","volume":"9","author":"Pruteanu","year":"2014","journal-title":"Evid Based Child Health"},{"key":"R331-2-20240830","doi-asserted-by":"crossref","first-page":"1700148","DOI":"10.1183\/13993003.00148-2017","article-title":"Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice","volume":"50","author":"Benard","year":"2017","journal-title":"Eur Respir J"},{"key":"R332-2-20240830","doi-asserted-by":"crossref","first-page":"1700148","DOI":"10.1183\/13993003.01984-2017","article-title":"Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice","volume":"50","author":"Urdaneta","year":"2017","journal-title":"Eur Respir J"},{"key":"R333-2-20240830","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jpeds.2019.02.009","article-title":"Montelukast and neuropsychiatric events in children with asthma: A nested case-control study","volume":"209","author":"Glockler-Lauf","year":"2019","journal-title":"J Pediatr"},{"key":"R334-2-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/02770900500446989","article-title":"Oral beta2-agonist use by preschool children with asthma in East and Central Harlem, New York","volume":"43","author":"Bonner","year":"2006","journal-title":"J Asthma"},{"key":"R335-2-20240830","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1001\/jama.285.20.2583","article-title":"Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial","volume":"285","author":"Lazarus","year":"2001","journal-title":"JAMA"},{"key":"R336-2-20240830","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ppul.20204","article-title":"Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing","volume":"39","author":"Deerojanawong","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"R337-2-20240830","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/adc.88.4.319","article-title":"Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode","volume":"88","author":"Drblik","year":"2003","journal-title":"Arch Dis Child"},{"key":"R338-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/23120541.00065-2018","article-title":"Spacer devices for inhaled therapy: Why use them, and how","volume":"4","author":"Vincken","year":"2018","journal-title":"ERJ Open Res"},{"key":"R339-2-20240830","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2004.04.007","article-title":"Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: A systematic review with meta-analysis","volume":"145","author":"Castro-Rodriguez","year":"2004","journal-title":"J Pediatr"},{"key":"R342-2-20240830","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pedn.2010.06.009","article-title":"Making education count: The nurse's role in asthma education using a medical home model of care","volume":"26","author":"Wood","year":"2011","journal-title":"J Pediatr Nurs"},{"key":"R343-2-20240830","first-page":"S3","article-title":"Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003","volume":"173","author":"Becker","year":"2005","journal-title":"CMAJ"},{"key":"R344-2-20240830","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2010.11.001","article-title":"Nutrients and foods for the primary prevention of asthma and allergy: Systematic review and meta-analysis","volume":"127","author":"Nurmatov","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R345-2-20240830","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/EDE.0b013e31824d5da2","article-title":"Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: A meta-analysis","volume":"23","author":"Pelucchi","year":"2012","journal-title":"Epidemiology"},{"key":"R346-2-20240830","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1164\/rccm.201304-0649ED","article-title":"Maternal distress and childhood wheeze: Mechanisms and context","volume":"187","author":"Kozyrskyj","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R347-2-20240830","doi-asserted-by":"crossref","first-page":"e20163000","DOI":"10.1542\/peds.2016-3000","article-title":"Early probiotic supplementation for eczema and asthma prevention: A randomized controlled trial","volume":"140","author":"Cabana","year":"2017","journal-title":"Pediatrics"},{"key":"R348-2-20240830","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/thoraxjnl-2018-211909","article-title":"Effectiveness of school-based self-management interventions for asthma among children and adolescents: Findings from a Cochrane systematic review and meta-analysis","volume":"74","author":"Kneale","year":"2019","journal-title":"Thorax"},{"key":"R350-2-20240830","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpam.2020.07.001","article-title":"Approach to childhood asthma in the era of COVID-19: The official statement endorsed by the Saudi Pediatric Pulmonology Association (SPPA)","volume":"7","author":"Al-Shamrani","year":"2020","journal-title":"Int J Pediatr Adolesc Med"},{"key":"R351-2-20240830","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children","volume":"360","author":"Ducharme","year":"2009","journal-title":"N Engl J Med"},{"key":"R352-2-20240830","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa054692","article-title":"Intermittent inhaled corticosteroids in infants with episodic wheezing","volume":"354","author":"Bisgaard","year":"2006","journal-title":"N Engl J Med"},{"key":"R353-2-20240830","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1398-9995.2009.02134.x","article-title":"Regular vs prn nebulized treatment in wheeze preschool children","volume":"64","author":"Papi","year":"2009","journal-title":"Allergy"},{"key":"R354-2-20240830","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R355-2-20240830","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma","volume":"354","author":"Guilbert","year":"2006","journal-title":"N Engl J Med"},{"key":"R356-2-20240830","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1164\/ajrccm.162.4.2002019","article-title":"The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children","volume":"162","author":"Nielsen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R357-2-20240830","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2007.08.063","article-title":"Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma","volume":"120","author":"Szefler","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R358-2-20240830","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1542\/peds.108.3.e48","article-title":"Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years","volume":"108","author":"Knorr","year":"2001","journal-title":"Pediatrics"},{"key":"R359-2-20240830","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1542\/peds.107.2.381","article-title":"Leukotriene modifiers in pediatric asthma management","volume":"107","author":"Bisgaard","year":"2001","journal-title":"Pediatrics"},{"key":"R361-2-20240830","doi-asserted-by":"crossref","first-page":"1900491","DOI":"10.1183\/13993003.00491-2019","article-title":"Asthma progression and mortality: The role of inhaled corticosteroids","volume":"54","author":"O'Byrne","year":"2019","journal-title":"Eur Respir J"},{"key":"R363-2-20240830","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/pch\/19.9.473","article-title":"Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma","volume":"19","author":"Chong","year":"2014","journal-title":"Paediatr Child Health"},{"key":"R364-2-20240830","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/ped.13268","article-title":"Risk factors hindering asthma symptom control in Saudi children and adolescents","volume":"59","author":"Halwani","year":"2017","journal-title":"Pediatr Int"},{"key":"R365-2-20240830","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.320.7246.1368","article-title":"Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)","volume":"320","author":"Shrewsbury","year":"2000","journal-title":"BMJ"},{"key":"R366-2-20240830","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1067\/mai.2001.114709","article-title":"Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations","volume":"107","author":"Matz","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R367-2-20240830","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1164\/rccm.201002-0193OC","article-title":"Combination therapy salmeterol\/fluticasone versus doubling dose of fluticasone in children with asthma","volume":"182","author":"Vaessen-Verberne","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R368-2-20240830","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/ajrccm.158.1.9706048","article-title":"Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group","volume":"158","author":"Verberne","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R371-2-20240830","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1183\/09031936.00008115","article-title":"Real-life long-term omalizumab therapy in children with severe allergic asthma","volume":"46","author":"Deschildre","year":"2015","journal-title":"Eur Respir J"},{"key":"R372-2-20240830","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40272-014-0107-z","article-title":"Omalizumab in children","volume":"16","author":"Licari","year":"2014","journal-title":"Paediatr Drugs"},{"key":"R373-2-20240830","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1185\/03007991003771338","article-title":"Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma","volume":"26","author":"Kulus","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"R374-2-20240830","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2009.09.021","article-title":"Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma","volume":"124","author":"Lanier","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R375-2-20240830","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/ppul.24508","article-title":"Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma","volume":"54","author":"Gupta","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"R376-2-20240830","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2019.08.005","article-title":"Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype","volume":"144","author":"Gupta","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R379-2-20240830","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/bmj.324.7353.1545","article-title":"Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: Systematic review of current evidence","volume":"324","author":"Ducharme","year":"2002","journal-title":"BMJ"},{"key":"R380-2-20240830","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)61777-2","article-title":"Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma","volume":"92","author":"Phipatanakul","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R381-2-20240830","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mpd.2001.112899","article-title":"Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study","volume":"138","author":"Simons","year":"2001","journal-title":"J Pediatr"},{"key":"R382-2-20240830","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1651-2227.2006.tb02264.x","article-title":"Asthma symptoms in early childhood--What happens then?","volume":"95","author":"Goks\u00f6r","year":"2006","journal-title":"Acta Paediatr"},{"key":"R383-2-20240830","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1081-1206(10)60226-8","article-title":"Predicting an asthma exacerbation in children 2 to 5 years of age","volume":"101","author":"Swern","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R385-2-20240830","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0895-4356(96)00027-3","article-title":"Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age","volume":"49","author":"Parkin","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R386-2-20240830","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1067\/mpd.2000.110121","article-title":"The Preschool Respiratory Assessment Measure (PRAM): A responsive index of acute asthma severity","volume":"137","author":"Chalut","year":"2000","journal-title":"J Pediatr"},{"key":"R387-2-20240830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/1817-1737.150735","article-title":"Poor asthma education and medication compliance are associated with increased emergency department visits by asthmatic children","volume":"10","author":"Al-Muhsen","year":"2015","journal-title":"Ann Thorac Med"},{"key":"R388-2-20240830","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jclinepi.2004.02.016","article-title":"Asthma severity scores for preschoolers displayed weaknesses in reliability, validity, and responsiveness","volume":"57","author":"Birken","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"R389-2-20240830","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/acem.12422","article-title":"PRAM score as predictor of pediatric asthma hospitalization","volume":"21","author":"Alnaji","year":"2014","journal-title":"Acad Emerg Med"},{"key":"R390-2-20240830","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.resuscitation.2013.05.018","article-title":"Development and validation of a decision tree early warning score based on routine laboratory test results for the discrimination of hospital mortality in emergency medical admissions","volume":"84","author":"Jarvis","year":"2013","journal-title":"Resuscitation"},{"key":"R391-2-20240830","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1542\/peds.106.5.1006","article-title":"Effectiveness of a clinical pathway for inpatient asthma management","volume":"106","author":"Johnson","year":"2000","journal-title":"Pediatrics"},{"key":"R392-2-20240830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pedhc.2008.10.004","article-title":"Childhood asthma practice guideline part three: Update of the 2007 National Guidelines for the Diagnosis and Treatment of Asthma. The National Asthma Education and Prevention Program","volume":"23","author":"Banasiak","year":"2009","journal-title":"J Pediatr Health Care"},{"key":"R393-2-20240830","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/pch\/17.5.251","article-title":"Canadian Paediatric Society, Acute Care Committee. Managing the paediatric patient with an acute asthma exacerbation","volume":"17","author":"Ortiz-Alvarez","year":"2012","journal-title":"Paediatr Child Health"},{"key":"R394-2-20240830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/adc.2006.097287","article-title":"Effect of a clinical pathway on the hospitalisation rates of children with asthma: A prospective study","volume":"92","author":"Norton","year":"2007","journal-title":"Arch Dis Child"},{"key":"R395-2-20240830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/ACI.0b013e328339731d","article-title":"Asthma care pathways in the emergency department","volume":"10","author":"Lougheed","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R396-2-20240830","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1440-1762.2001.00405.x","article-title":"The benefits of using clinical pathways for managing acute paediatric illness in an emergency department","volume":"21","author":"Browne","year":"2001","journal-title":"J Qual Clin Pract"},{"key":"R397-2-20240830","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(82)91619-1","article-title":"Routine antibiotics in hospital management of acute asthma","volume":"1","author":"Graham","year":"1982","journal-title":"Lancet"},{"key":"R401-2-20240830","first-page":"234","article-title":"Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children","volume":"14","author":"Griffiths","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"R403-2-20240830","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/adc.2004.050005","article-title":"A meta-analysis on intravenous magnesium sulphate for treating acute asthma","volume":"90","author":"Cheuk","year":"2005","journal-title":"Arch Dis Child"},{"key":"R404-2-20240830","doi-asserted-by":"crossref","first-page":"v","DOI":"10.3310\/hta17450","article-title":"MAGNEsium Trial In Children (MAGNETIC): A randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children","volume":"17","author":"Powell","year":"2013","journal-title":"Health Technol Assess"},{"key":"R405-2-20240830","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(13)70037-7","article-title":"Magnesium sulphate in acute severe asthma in children (MAGNETIC): A randomised, placebo-controlled trial","volume":"1","author":"Powell","year":"2013","journal-title":"Lancet Respir Med"},{"key":"R407-2-20240830","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.92.4.513","article-title":"Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma","volume":"92","author":"Scarfone","year":"1993","journal-title":"Pediatrics"},{"key":"R408-2-20240830","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"R409-2-20240830","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R410-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200363002-00002","article-title":"Treatment options for initial maintenance therapy of persistent asthma: A review of inhaled corticosteroids and leukotriene receptor antagonists","volume":"63","author":"Creticos","year":"2003","journal-title":"Drugs"},{"key":"R411-2-20240830","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.285.20.2594","article-title":"Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: A randomized controlled trial","volume":"285","author":"Lemanske","year":"2001","journal-title":"JAMA"},{"key":"R412-2-20240830","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/thx.2004.039180","article-title":"Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma","volume":"60","author":"Masoli","year":"2005","journal-title":"Thorax"},{"key":"R413-2-20240830","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/1817-1737.102188","article-title":"Budesonide and fluticasone and adrenal suppression","volume":"7","author":"Fouda","year":"2012","journal-title":"Ann Thorac Med"},{"key":"R414-2-20240830","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jaci.2009.09.050","article-title":"Particle size of inhaled corticosteroids: Does it matter?","volume":"124","author":"Leach","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R415-2-20240830","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1398-9995.2007.01376.x","article-title":"Differential anti-inflammatory effects of large and small particle size inhaled corticosteroids in asthma","volume":"62","author":"Menzies","year":"2007","journal-title":"Allergy"},{"key":"R418-2-20240830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/ped.2013.0244","article-title":"Does use of inhaled corticosteroid for management of asthma in children make them shorter adults?","volume":"26","author":"Raissy","year":"2013","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"R419-2-20240830","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40413-016-0117-0","article-title":"The use of inhaled corticosteroids in pediatric asthma: Update","volume":"9","author":"Hossny","year":"2016","journal-title":"World Allergy Organ J"},{"key":"R420-2-20240830","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1177\/1060028013503125","article-title":"Effect of inhaled corticosteroids on long-term growth in pediatric patients with asthma and allergic rhinitis","volume":"47","author":"Hoover","year":"2013","journal-title":"Ann Pharmacother"},{"key":"R421-2-20240830","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1542\/peds.2007-3381","article-title":"Effect of long-term corticosteroid use on bone mineral density in children: A prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study","volume":"122","author":"Kelly","year":"2008","journal-title":"Pediatrics"},{"key":"R422-2-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppul.22968","article-title":"Inhaled corticosteroids and bone mineral density at school age: A follow-up study after early childhood wheezing","volume":"50","author":"Sidoroff","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"R423-2-20240830","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pupt.2011.01.004","article-title":"Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children","volume":"24","author":"Stelmach","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"R424-2-20240830","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1157\/13077744","article-title":"The effects of long term use of inhaled corticosteroids on linear growth, adrenal function and bone mineral density in children","volume":"33","author":"Altintas","year":"2005","journal-title":"Allergol Immunopathol (Madr"},{"key":"R425-2-20240830","first-page":"76","article-title":"The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma","volume":"57","author":"Bjermer","year":"2002","journal-title":"Monaldi Arch Chest Dis"},{"key":"R426-2-20240830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/1817-1737.33696","article-title":"Blocking leukotrienes optimize asthma control: The BLOC survey","volume":"2","author":"Idrees","year":"2007","journal-title":"Ann Thorac Med"},{"key":"R427-2-20240830","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.200207-747OC","article-title":"Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis","volume":"167","author":"Bisgaard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R428-2-20240830","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.127.2.509","article-title":"The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old","volume":"127","author":"Straub","year":"2005","journal-title":"Chest"},{"key":"R429-2-20240830","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1183\/09031936.05.00031904","article-title":"The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma","volume":"25","author":"Straub","year":"2005","journal-title":"Eur Respir J"},{"key":"R430-2-20240830","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200407-894OC","article-title":"Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma","volume":"171","author":"Bisgaard","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R431-2-20240830","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1183\/09031936.00121411","article-title":"24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids","volume":"40","author":"L\u00f6tvall","year":"2012","journal-title":"Eur Respir J"},{"key":"R432-2-20240830","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1124\/jpet.111.179259","article-title":"Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol","volume":"337","author":"Casarosa","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R433-2-20240830","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1081-1206(10)60840-X","article-title":"Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma","volume":"101","author":"Pearlman","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R434-2-20240830","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.rmed.2010.06.011","article-title":"24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol","volume":"104","author":"Sugihara","year":"2010","journal-title":"Respir Med"},{"key":"R435-2-20240830","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MCP.0b013e32833303d2","article-title":"Novel bronchodilators in asthma","volume":"16","author":"Cazzola","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"R436-2-20240830","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/bjp.2008.284","article-title":"Novel long-acting bronchodilators for COPD and asthma","volume":"155","author":"Cazzola","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R437-2-20240830","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1185\/03007990903143143","article-title":"24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: Comparison with placebo and formoterol","volume":"25","author":"LaForce","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"R439-2-20240830","first-page":"63","article-title":"Long-acting anti-muscarinic agents (LAMA) frequency of use and clinical features of patients with severe asthma in real-life setting: Data from the Severe Asthma Network in Italy (SANI) registry","volume":"54","author":"Puggioni","year":"2019","journal-title":"Eur Respiratory Soc"},{"key":"R440-2-20240830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14728214.2020.1758059","article-title":"Emerging muscarinic receptor antagonists for the treatment of asthma","volume":"25","author":"Matera","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"R441-2-20240830","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thorax.55.4.289","article-title":"A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group","volume":"55","author":"van Noord","year":"2000","journal-title":"Thorax"},{"key":"R442-2-20240830","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/09031936.95.08091506","article-title":"Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: A pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group","volume":"8","author":"Maesen","year":"1995","journal-title":"Eur Respir J"},{"key":"R443-2-20240830","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.rmed.2006.11.001","article-title":"A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma","volume":"101","author":"Fardon","year":"2007","journal-title":"Respir Med"},{"key":"R444-2-20240830","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma.: A systematic review with meta-analysis?","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"key":"R446-2-20240830","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1172\/JCI17748","article-title":"New insights into the pathogenesis of asthma","volume":"111","author":"Elias","year":"2003","journal-title":"J Clin Invest"},{"key":"R447-2-20240830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/1817-1737.30361","article-title":"New insights into the pathophysiology of the small airways in asthma","volume":"2","author":"Hamid","year":"2007","journal-title":"Ann Thorac Med"},{"key":"R449-2-20240830","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13063-016-1731-4","article-title":"The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide\/formoterol given 'as needed' in mild asthma: Study protocols for two randomised controlled trials","volume":"18","author":"O'Byrne","year":"2017","journal-title":"Trials"},{"key":"R450-2-20240830","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.rmed.2008.09.002","article-title":"Lung function and asthma control with beclomethasone and formoterol in a single inhaler","volume":"103","author":"Huchon","year":"2009","journal-title":"Respir Med"},{"key":"R451-2-20240830","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.rmed.2013.02.010","article-title":"Dose-dependent anti-inflammatory effect of inhaled mometasone furoate\/formoterol in subjects with asthma","volume":"107","author":"Nolte","year":"2013","journal-title":"Respir Med"},{"key":"R452-2-20240830","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/jphp.12303","article-title":"Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol","volume":"66","author":"Grekas","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"R453-2-20240830","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.rmed.2010.11.011","article-title":"Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler","volume":"105","author":"Bodzenta-Lukaszyk","year":"2011","journal-title":"Respir Med"},{"key":"R454-2-20240830","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/thoraxjnl-2013-203600","article-title":"Once-daily fluticasone furoate (FF)\/vilanterol reduces risk of severe exacerbations in asthma versus FF alone","volume":"69","author":"Bateman","year":"2014","journal-title":"Thorax"},{"key":"R455-2-20240830","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2012-202606","article-title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the \u03b22 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: A randomised trial","volume":"68","author":"Busse","year":"2013","journal-title":"Thorax"},{"key":"R456-2-20240830","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/cea.13702","article-title":"Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics","volume":"50","author":"Jabbal","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"R458-2-20240830","first-page":"723","article-title":"Critical appraisal of the therapy of asthma--an idea whose time has come","volume":"133","author":"McFadden","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"R459-2-20240830","first-page":"365","article-title":"Emergency therapy of asthma: Comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline","volume":"122","author":"Rossing","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"R460-2-20240830","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1378\/chest.122.1.160","article-title":"Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: A systematic review with meta-analysis","volume":"122","author":"Rodrigo","year":"2002","journal-title":"Chest"},{"key":"R461-2-20240830","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1378\/chest.122.4.1200","article-title":"The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: A meta-analysis","volume":"122","author":"Travers","year":"2002","journal-title":"Chest"},{"key":"R462-2-20240830","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1378\/chest.114.2.365","article-title":"The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: A pooled analysis of three trials","volume":"114","author":"Lanes","year":"1998","journal-title":"Chest"},{"key":"R463-2-20240830","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0196-0644(99)70266-0","article-title":"The role of ipratropium bromide in the emergency management of acute asthma exacerbation: A metaanalysis of randomized clinical trials","volume":"34","author":"Stoodley","year":"1999","journal-title":"Ann Emerg Med"},{"key":"R464-2-20240830","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9343(99)00243-0","article-title":"A meta-analysis of the effects of ipratropium bromide in adults with acute asthma","volume":"107","author":"Rodrigo","year":"1999","journal-title":"Am J Med"},{"key":"R465-2-20240830","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1164\/ajrccm.161.6.9908115","article-title":"First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department","volume":"161","author":"Rodrigo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R466-2-20240830","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1378\/chest.121.6.1977","article-title":"The role of anticholinergics in acute asthma treatment: An evidence-based evaluation","volume":"121","author":"Rodrigo","year":"2002","journal-title":"Chest"},{"key":"R469-2-20240830","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.122.2.489","article-title":"IV magnesium sulfate in the treatment of acute severe asthma: A multicenter randomized controlled trial","volume":"122","author":"Silverman","year":"2002","journal-title":"Chest"},{"key":"R471-2-20240830","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2125.2008.03153.x","article-title":"Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler","volume":"66","author":"Nair","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R472-2-20240830","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.rmed.2011.07.004","article-title":"Inhaler technique and asthma: Feasability and acceptability of training by pharmacists","volume":"105","author":"Giraud","year":"2011","journal-title":"Respir Med"},{"key":"R473-2-20240830","first-page":"323","article-title":"Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): The SYSTER survey","volume":"13","author":"Giraud","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R474-2-20240830","first-page":"7","article-title":"Inhaled corticosteroid delivery systems: Clinical role of a breath-actuated device","volume":"5","author":"Donnell","year":"2001","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R475-2-20240830","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1056\/NEJMe1806037","article-title":"New Biologics for Asthma","volume":"378","author":"Drazen","year":"2018","journal-title":"N Engl J Med"},{"key":"R476-2-20240830","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: An analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R478-2-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yrtph.2014.12.002","article-title":"Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE","volume":"71","author":"Lowe","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"R479-2-20240830","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/all.14221","article-title":"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"R480-2-20240830","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: A secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R481-2-20240830","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"R482-2-20240830","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: Pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R483-2-20240830","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.anai.2018.01.030","article-title":"Benralizumab efficacy by atopy status and serum immunoglobulin E for patients with severe, uncontrolled asthma","volume":"120","author":"Chipps","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R484-2-20240830","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"R485-2-20240830","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1164\/rccm.201707-1323OC","article-title":"Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab","volume":"197","author":"Mukherjee","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R486-2-20240830","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-2600(18)30406-5","article-title":"Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial","volume":"7","author":"Busse","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R487-2-20240830","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.anai.2019.02.016","article-title":"Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma","volume":"122","author":"Chupp","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R490-2-20240830","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/all.14235","article-title":"Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - Recommendations on the use of biologicals in severe asthma","volume":"75","author":"Agache","year":"2020","journal-title":"Allergy"},{"key":"R491-2-20240830","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(19)33005-3","article-title":"Intersection of biology and therapeutics: Type 2 targeted therapeutics for adult asthma","volume":"395","author":"Peters","year":"2020","journal-title":"Lancet"},{"key":"R492-2-20240830","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in Adults with Uncontrolled Asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"key":"R493-2-20240830","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","article-title":"Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial","volume":"80","author":"Simpson","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R494-2-20240830","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12931-020-01503-z","article-title":"SOURCE: A phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma","volume":"21","author":"Wechsler","year":"2020","journal-title":"Respir Res"},{"key":"R495-2-20240830","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12931-020-01526-6","article-title":"NAVIGATOR: A phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"21","author":"Menzies-Gow","year":"2020","journal-title":"Respir Res"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_697_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:36:47Z","timestamp":1787845007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.ATM_697_20"}},"subtitle":["Guidelines for the diagnosis and management of asthma in adults and children"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":446,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/atm.atm_697_20","relation":{},"ISSN":["1817-1737"],"issn-type":[{"value":"1817-1737","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}